DYRK1A and Alzheimer disease: The same compound inhibited DYRK1A-induced τ phosphorylation at multiple AD-relevant sites, including Ser396, Thr212, and Thr231 in biochemical assays, cell lines (e.g., HEK293 cells), and primary cortical neurons without affecting cell viability.